Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targetsXiangyuan Luo, Xingxing He|Journal of Experimental & Clinical Cancer Research|2021Cited by 216
YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transitionXiangyuan Luo, Xingxing He|Experimental Hematology and Oncology|2021Cited by 101
SRSF10 inhibition prevents HCC growth and metastasis and enhances the anti-PD-L1- mediated tumor suppressionXiangyuan Luo, Limin Xia|Research Square|2023Cited by 0